The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Indoramin 20 mg Film-coated Tablets

Chemidex Pharma LimitedPA22643/004/001

Main Information

Trade NameIndoramin 20 mg Film-coated Tablets
Active SubstancesIndoramin base
Dosage FormFilm-coated tablet
Licence HolderChemidex Pharma Limited
Licence NumberPA22643/004/001

Group Information

ATC CodeC02CA Alpha-adrenoreceptor antagonists
C02CA02 indoramin


License statusAuthorised
Licence Issued29/02/2008
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back